Since Operation Desert Shield/Desert Storm, Gulf War veterans have expressed concerns that their postdeployment medical symptoms could have been caused by hazardous exposures or other deployment-related factors. Potential exposure to a broad range of CB and other harmful agents was not unique to Gulf operations. Hazardous exposures have been a component of all military operations in this century. Nevertheless, the Gulf War deployment focused national attention on the potential, but uncertain, relationship between the presence of CB agents in theater and symptoms reported by military personnel. Particular attention has been given to the potential long-term health effects of low-level exposures to CB agents.
In the spring of 1996, Deputy Secretary of Defense John White met with the leadership of the National Academies to discuss the DoD's continuing efforts to improve protection of military personnel from adverse health effects during deployments in hostile environments. Although many lessons learned from previous assessments of Operation Desert Shield/Desert Storm have been reported, prospective analyses are still needed. Strategies to Protect the Health of Deployed U.S. Forces: Force Protection and Decontamination, which addresses the issues of physical protection and decontamination, is one of four initial reports that will be submitted in response to that request.
Specifically, this report includes a review and evaluation of the following areas:
Table of Contents
|2 Threat and Risk Assessment||23-57|
|3 Philosophy, Doctrine, and Training for Chemical and Biological Warfare||58-66|
|4 Physical Protection||67-107|
|6 Testing and Evaluation||138-150|
|7 Assessment of Military Capabilities to Provide Emergency Response||151-154|
|8 Summary and General Recommendations||155-163|
|Appendix A: Funding Levels||179-181|
|Appendix B: Textiles and Garments for Chemical and Biological Protection||182-216|
|Appendix C: Evaluations of Barrier Creams||217-220|
|Appendix D: Evaluating Skin Decontamination Techniques||221-223|
|Appendix E: Percutaneous Absorption||224-229|
|Appendix F: Contributors to The Study||230-235|
|Appendix G: Biographical Sketches of Principal Investigators and Members of the Advisory Panel||236-238|
The National Academies Press (NAP) has partnered with Copyright Clearance Center's Rightslink service to offer you a variety of options for reusing NAP content. Through Rightslink, you may request permission to reprint NAP content in another publication, course pack, secure website, or other media. Rightslink allows you to instantly obtain permission, pay related fees, and print a license directly from the NAP website. The complete terms and conditions of your reuse license can be found in the license agreement that will be made available to you during the online order process. To request permission through Rightslink you are required to create an account by filling out a simple online form. The following list describes license reuses offered by the National Academies Press (NAP) through Rightslink:
Click here to obtain permission for the above reuses. If you have questions or comments concerning the Rightslink service, please contact:
Rightslink Customer Care
Tel (toll free): 877/622-5543
To request permission to distribute a PDF, please contact our Customer Service Department at 800-624-6242 for pricing.
To request permission to translate a book published by the National Academies Press or its imprint, the Joseph Henry Press, please click here to view more information.